Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Comment by miles44on Oct 29, 2020 6:27pm
182 Views
Post# 31810253

RE:RE:RE:RE:RE:RE:RE:Gap to fill at CA$.115

RE:RE:RE:RE:RE:RE:RE:Gap to fill at CA$.115well, as for Q4 we will have some costs guidance next wednesday. The information I have is that total costs in Q3 were at around 1.10/1.11 so @firecracker74 s calculations were correct, counting in an operating loss plus a small net profit due to the pricing gain.

As for Q4 total costs should already be down to 1.02, thats "all inclusive", also including TC 300.

So of course no-one knows the zinc prices of November and December, but I do suppose that TV has already done some hedging to save the net profit for Q4 as they have to (and will) meet with credit covenants at year end.

With TC 200 in 2021, TV should have total costs of around 1 USD as I already mentioned with higher capex in 2021.

I also doubt that we ll get rid of the going concern wording in Q3 already, but there s a tiny possibility: If you look at the criteria for financial statements, "going concern" is the normal state of a company that is presumed and a going concern warning therefore will disappear once it can be presumed again that "for the foreseeable future" = normally 6 months, the company will continue as a going concern. So if one would suppose that Q3 was profitable, but with an operating loss and Q4 would e.g. already be mostly hedged, plus one would argue that it could be presumed that we d see treatment charges at 200 USD in 2021, that would mean, the gc warning could disappear now.

But of  course stakes are higher that we ll once again see the warning and get rid of it only after Q4.... and you d be right then with your idea of rising prices in spring... 


<< Previous
Bullboard Posts
Next >>